Kwong Choo

Interim CFO @ Ondine Biomedical arrow icon

Kwong Choo is an experienced Interim CFO with over 20 years of leadership in various industries, known for his expertise in public company reporting, M&A, and financial strategies.

Kwong Choo's Title

Kwong Choo currently serves as the Interim CFO, leveraging over 20 years of expansive leadership experience across various high-stakes industries. His role involves overseeing financial strategies, ensuring regulatory compliance, and driving fiscal efficiencies to support the company's growth and stability.

Kwong Choo's Experience

Kwong Choo's extensive experience spans over two decades and includes pivotal roles in biotechnology/pharmaceutical, manufacturing/distribution, real estate, and start-ups. He has a robust background in public company reporting and regulatory compliance, particularly with TSX, TSX-V, and NASDAQ markets. His adeptness in managing financial operations and regulatory frameworks has made him a valuable asset in the corporate world.

Kwong Choo's Achievements

One of Kwong Choo's significant achievements includes leading the reverse takeover of a TSX-V company, a complex transaction that requires meticulous planning and execution. He has also been instrumental in raising CAD$25 million in equity financing, demonstrating his capability in securing substantial investments to fuel company growth. Additionally, his leadership in M&A due diligence and internal controls implementation has helped companies streamline operations and enhance financial integrity.

Kwong Choo's Financial Expertise

Kwong Choo brings a diversified financial expertise to the table, particularly in publicly traded companies. His proficiency includes improving financial and operational efficiencies, developing tax strategies, and leading regulatory compliance efforts. His extensive knowledge in these areas ensures that companies not only meet regulatory standards but also achieve optimal financial performance.

Kwong Choo's Background in M&A and Equity Financing

Kwong Choo has a proven track record in mergers and acquisitions (M&A) and equity financing. His role in M&A due diligence and internal controls has been pivotal in ensuring smooth transactions and integrations. Furthermore, his success in raising CAD$25 million in equity financing underscores his ability to attract and manage significant investments, crucial for the growth and expansion of companies.

report flag Report inaccurate information

People similar to Kwong Choo

Simon Sinclair is a seasoned medical professional and executive, currently serving as the CMO, with a strong background in clinical development and medical affairs across major healthcare companies.

Bill Kanz

SVP – Engineering & Operations @ Ondine Biomedical

Bill Kanz is a seasoned engineering professional with over 30 years of experience in the medical device sector, specializing in various engineering disciplines.

Roger Andersen

VP – Regulatory & Medical @ Ondine Biomedical

Roger Andersen is the VP of Regulatory & Medical, holding MD and MPH degrees, with a background in medicine and clinical research.